Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

PURPOSE: Deletions of chromosome 1 have been described in 7-40% of cases of myeloma with inconsistent clinical consequences. CDKN2C at 1p32.3 has been identified in myeloma cell lines as the potential target of the deletion. We tested the clinical impact of 1p deletion and used high resolution techn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leone, Paola E., Walker, Brian A., Jenner, Matthew W., Chiecchio, Laura, Dagrada, GianPaolo, Protheroe, Rebecca K.M., Johnson, David C., Dickens, Nicholas J., Brito, Jose Luis, Else, Monica, Gonzalez, David, Ross, Fiona M., Chen-Kiang, Selina, Davies, Faith E., Morgan, Gareth J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581792/
https://ncbi.nlm.nih.gov/pubmed/18829482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados